ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -8.3% ·
flujo de acciones -12.3% ·
nuevas posiciones netas -9.1%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | — |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | — | — |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | — | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | — | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | — |
| Q2 2024 | 9 | — | 3.87M | $50.19M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Marshall Wace ✦ | 930.09K | +9.3% | $5.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Marshall Wace ✦ | 930.09K | +9.3% | $5.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Marshall Wace ✦ | 930.09K | +9.3% | $5.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 896.99K | +22.7% | $5.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 498.00K | -5.1% | $2.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 477.23K | 0.0% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 477.23K | 0.0% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (pasivo) | 460.98K | — | $2.65M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 421.59K | -15.9% | $2.42M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 421.59K | -15.9% | $2.42M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 158.26K | -76.5% | $909,984 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 64.28K | -66.4% | $369,627 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 51.30K | +47.6% | $294,964 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 51.30K | +47.6% | $294,964 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 46.10K | +21.8% | $265,070 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 46.10K | +21.8% | $265,070 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 46.10K | +21.8% | $265,070 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Norges Bank ✦ (pasivo) | 40.70K | 0.0% | $234,025 | 0.0% | Held | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $903,288 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 131 tenedores, 26.72M acciones, $290.62M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.